Results of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Fayette, J., Lefebvre, G., Posner, M.R., Bauman, J., Salas, S., Even, C., Saada-Bouzid, E., Seiwert, T., Colevas, D., Calmels, F., Zerbib, R., Boyer Chammard, A., Cohen, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?
Faivre, L, Boucher, H, Zerbib, R, Domet, T, Desproges, A, Couzin, C, Vanneaux, V, Larghero, J, Cras, A
Published in Bone marrow transplantation (Basingstoke) (01.09.2017)
Published in Bone marrow transplantation (Basingstoke) (01.09.2017)
Get full text
Journal Article
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial
KROPFF, Martin, GIONGCO BAYLON, Honorata, AVET-LOISEAU, Herve, MOEHLER, Thomas M, PATTOU, Claire, LUCY, Lela, KUEENBURG, Elisabeth, GLASMACHER, Axel, ZERBIB, Robert, FACON, Thierry, HILLENGASS, Jens, ROBAK, Tadeusz, HAJEK, Roman, LIEBISCH, Peter, GORANOV, Stefan, HULIN, Cyrille, BLADE, Joan, CARAVITA, Tommaso
Published in Haematologica (Roma) (01.05.2012)
Published in Haematologica (Roma) (01.05.2012)
Get full text
Journal Article
Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours
Massard, C., Cassier, P., Bendell, J.C., Marie, D.B., Blery, M., Morehouse, C., Ascierto, M., Zerbib, R., Mitry, E., Tolcher, A.W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1203P - Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours
Massard, C., Cassier, P., Bendell, J.C., Marie, D.B., Blery, M., Morehouse, C., Ascierto, M., Zerbib, R., Mitry, E., Tolcher, A.W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1203PPreliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours
Massard, C, Cassier, P, Bendell, J C, Marie, D B, Blery, M, Morehouse, C, Ascierto, M, Zerbib, R, Mitry, E, Tolcher, A W
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1134PMonalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data
Cohen, R B, Lefebvre, G, Posner, M R, Bauman, J R, Salas, S, Even, C, Saada-Bouzid, E, Seiwert, T, Colevas, D, Calmels, F, Zerbib, R, André, P, Boyer-Chammard, A, Fayette, J
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Monalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data
Cohen, R.B., Lefebvre, G., Posner, M.R., Bauman, J.R., Salas, S., Even, C., Saada-Bouzid, E., Seiwert, T., Colevas, D., Calmels, F., Zerbib, R., André, P., Boyer-Chammard, A., Fayette, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1134P - Monalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data
Cohen, R.B., Lefebvre, G., Posner, M.R., Bauman, J.R., Salas, S., Even, C., Saada-Bouzid, E., Seiwert, T., Colevas, D., Calmels, F., Zerbib, R., André, P., Boyer-Chammard, A., Fayette, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1049PDResults of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Fayette, J, Lefebvre, G, Posner, M R, Bauman, J, Salas, S, Even, C, Saada-Bouzid, E, Seiwert, T, Colevas, D, Calmels, F, Zerbib, R, Boyer Chammard, A, Cohen, R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study
Abgrall, JF, Guibaud, I, Bastie, JN, Flesch, M, Rossi, JF, Lacotte-Thierry, L, Boyer, F, Casassus, P, Slama, B, Berthou, C, Rodon, P, Leporrier, M, Villemagne, B, Himberlin, C, Ghomari, K, Larosa, F, Rollot, F, Dugay, J, Allard, C, Maigre, M, Isnard, F, Zerbib, R, Cauvin, JM, Groupe Ouest-Est Leucemies et Maladies du Sang (GOELAMS)
Published in Haematologica (Roma) (01.08.2006)
Get full text
Published in Haematologica (Roma) (01.08.2006)
Journal Article
A multicenter prospective randomized study testing non-inferiority of thalidomide 100 mg/day as compared with 400 mg/day in patients with refractory/relapsed multiple myeloma: Results of the final analysis of the IFM 01–02 study
Yakoub-Agha, I., Doyen, C., Hulin, C., Marit, G., Voillat, L., Grosbois, B., Harousseau, J., Duguet, C., Zerbib, R., Facon, T., Mary, J.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
A Multicenter Prospective Randomized Study Testing Non-Inferiority of Thalidomide 100 mg/day as Compared with 400 mg/day in Patients with Refractory/Relapsed Multiple Myeloma: First Results of the Final Analysis of the IFM 01-02 Study
Yakoub-Agha, Ibrahim, Hulin, C., Doyen, C., Benboubker, L., Voillat, L., Bouabdallah, K., Guillerm, G., Moreau, P., Maloisel, F., Stoppa, A.M., Pegourie, B., Rodon, P., Dib, M., Casassus, P., Slama, B., Voog, E., Jardel, H., Collet, P., Wettervald, M., Peny, A.M., Mineur, P., Duguet, C., Zerbib, R., Facon, T., Mary, J.Y.
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
A404 OPTIMUM Trial: Randomized Comparison of Thalidomide Versus Dexamethasone for Relapsed Myeloma
Kropff, M, Baylon, H, Spicka, I, Hillengass, J, Roback, T, Salwender, H, Hajek, R, Liebisch, P, Boskowic, D, Goranov, S, Zerbib, R
Published in Clinical lymphoma & myeloma (01.02.2009)
Published in Clinical lymphoma & myeloma (01.02.2009)
Get full text
Journal Article
Three-dimensional organization of tubular and filamentous nuclear inclusions and associated structures in sympathetic neurons as revealed by serial sections and tilting experiments
Seite, R., Vuillet-Luciani, J., Zerbib, R., Cataldo, C., Escaig, J., Pebusque, M.J., Autillo-Touati, A.
Published in Journal of ultrastructure research (1979)
Published in Journal of ultrastructure research (1979)
Get full text
Journal Article
Traitement du myélome multiple en phase avancée par le thalidomide : étude prospective sur 121 patients avec dosage sérique de thalidomide chez 39 patients
Grosbois, B., Bellissant, E., Zerbib, R., Muret, P., Moreau, P., Voillat, L., Attal, M., Yakoub-Agha, I.
Published in La revue de medecine interne (01.06.2001)
Published in La revue de medecine interne (01.06.2001)
Get full text
Journal Article